{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:07:49Z","timestamp":1791655669011,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01379-y","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:05:43Z","timestamp":1768230343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mendelian randomization study of GLP-1R effects on ovarian cancer subtypes mediated by metabolic factors"],"prefix":"10.1038","volume":"6","author":[{"given":"Jiajia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-4132","authenticated-orcid":false,"given":"Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5950-2732","authenticated-orcid":false,"given":"Zhiyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-6839","authenticated-orcid":false,"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12935-025-03658-5","volume":"25","author":"AF Ajayi","year":"2025","unstructured":"Ajayi, A. F., Oyovwi, M. O., Akano, O. P., Akanbi, G. B. & Adisa, F. B. Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer. Cancer Cell Int. 25, 33 (2025).","journal-title":"Cancer Cell Int."},{"key":"1379_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb, P. M. & Jordan, S. J. Global epidemiology of epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 21, 389\u2013400 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1379_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","volume":"4","author":"KR Cho","year":"2009","unstructured":"Cho, K. R. & Shih, I.-M. Ovarian cancer. Annu. Rev. Pathol. 4, 287\u2013313 (2009).","journal-title":"Annu. Rev. Pathol."},{"key":"1379_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ng.3826","volume":"49","author":"CM Phelan","year":"2017","unstructured":"Phelan, C. M. et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat. Genet. 49, 680\u2013691 (2017).","journal-title":"Nat. Genet."},{"key":"1379_CR5","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","volume":"34","author":"N Wentzensen","year":"2016","unstructured":"Wentzensen, N. et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J. Clin. Oncol. 34, 2888\u20132898 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1379_CR6","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff, A. M. et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N. Engl. J. Med. 389, 2221\u20132232 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1379_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa2302392","volume":"389","author":"S Wharton","year":"2023","unstructured":"Wharton, S. et al. Daily Oral GLP-1 receptor agonist orforglipron for adults with obesity. N. Engl. J. Med. 389, 877\u2013888 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1379_CR8","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1056\/NEJMcibr2108627","volume":"385","author":"G Srivastava","year":"2021","unstructured":"Srivastava, G. & Kumar, R. B. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med. 385, e4 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1379_CR9","first-page":"182","volume":"43","author":"American Diabetes Association Primary Care Advisory Group","year":"2025","unstructured":"American Diabetes Association Primary Care Advisory Group Standards of Care in Diabetes\u20142025 Abridged for Primary Care. Clin. Diab. 43, 182 (2025).","journal-title":"Clin. Diab."},{"key":"1379_CR10","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s10555-024-10192-9","volume":"43","author":"SS Ibrahim","year":"2024","unstructured":"Ibrahim, S. S. et al. The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer. Cancer Metastasis Rev. 43, 1297\u20131314 (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"1379_CR11","doi-asserted-by":"publisher","first-page":"e078225","DOI":"10.1136\/bmj-2023-078225","volume":"385","author":"B Pasternak","year":"2024","unstructured":"Pasternak, B. et al. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: scandinavian cohort study. BMJ 385, e078225 (2024).","journal-title":"BMJ"},{"key":"1379_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng, Z. et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct. Target Ther. 9, 234 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"1379_CR13","doi-asserted-by":"publisher","first-page":"e2421305","DOI":"10.1001\/jamanetworkopen.2024.21305","volume":"7","author":"L Wang","year":"2024","unstructured":"Wang, L., Xu, R., Kaelber, D. C. & Berger, N. A. Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes. JAMA Netw. Open 7, e2421305 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1379_CR14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00228-024-03761-y","volume":"80","author":"J-L Montastruc","year":"2024","unstructured":"Montastruc, J.-L. GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase\u00ae. Eur. J. Clin. Pharm. 80, 1999\u20132001 (2024).","journal-title":"Eur. J. Clin. Pharm."},{"key":"1379_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(19)31271-1","volume":"394","author":"R Pratley","year":"2019","unstructured":"Pratley, R. et al. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet 394, 39\u201350 (2019).","journal-title":"Lancet"},{"key":"1379_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311\u2013322 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1379_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","volume":"392","author":"PM O\u2019Neil","year":"2018","unstructured":"O\u2019Neil, P. M. et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet 392, 637\u2013649 (2018).","journal-title":"Lancet"},{"key":"1379_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32, 1\u201322 (2003).","journal-title":"Int. J. Epidemiol."},{"key":"1379_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng, J. et al. Recent developments in mendelian randomization studies. Curr. Epidemiol. Rep. 4, 330\u2013345 (2017).","journal-title":"Curr. Epidemiol. Rep."},{"key":"1379_CR20","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1097\/JS9.0000000000001514","volume":"110","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials. Int. J. Surg. 110, 4688\u20134694 (2024).","journal-title":"Int. J. Surg."},{"key":"1379_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00125-023-05925-4","volume":"66","author":"J Yarmolinsky","year":"2023","unstructured":"Yarmolinsky, J. et al. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. Diabetologia 66, 1481\u20131500 (2023).","journal-title":"Diabetologia"},{"key":"1379_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ygyno.2024.07.008","volume":"190","author":"CJ Riedinger","year":"2024","unstructured":"Riedinger, C. J. et al. Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: a review for the gynecologic oncologist. Gynecol. Oncol. 190, 1\u201310 (2024).","journal-title":"Gynecol. Oncol."},{"key":"1379_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter, A. R. et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur. J. Epidemiol. 36, 465\u2013478 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"1379_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41467-020-20578-2","volume":"12","author":"D Garrido-Mart\u00edn","year":"2021","unstructured":"Garrido-Mart\u00edn, D., Borsari, B., Calvo, M., Reverter, F. & Guig\u00f3, R. Identification and analysis of splicing quantitative trait loci across multiple tissues in the human genome. Nat. Commun. 12, 727 (2021).","journal-title":"Nat. Commun."},{"key":"1379_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"1379_CR26","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"key":"1379_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41588-023-01300-6","volume":"55","author":"N de Klein","year":"2023","unstructured":"de Klein, N. et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat. Genet. 55, 377\u2013388 (2023).","journal-title":"Nat. Genet."},{"key":"1379_CR28","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41588-021-00923-x","volume":"53","author":"JL Min","year":"2021","unstructured":"Min, J. L. et al. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation. Nat. Genet. 53, 1311\u20131321 (2021).","journal-title":"Nat. Genet."},{"key":"1379_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ajhg.2021.01.012","volume":"108","author":"C Robins","year":"2021","unstructured":"Robins, C. et al. Genetic control of the human brain proteome. Am. J. Hum. Genet. 108, 400\u2013410 (2021).","journal-title":"Am. J. Hum. Genet"},{"key":"1379_CR30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41593-021-00832-6","volume":"24","author":"TS Wingo","year":"2021","unstructured":"Wingo, T. S. et al. Brain proteome-wide association study implicates novel proteins in depression pathogenesis. Nat. Neurosci. 24, 810\u2013817 (2021).","journal-title":"Nat. Neurosci."},{"key":"1379_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73\u201379 (2018).","journal-title":"Nature"},{"key":"1379_CR32","doi-asserted-by":"publisher","first-page":"e16359","DOI":"10.15252\/emmm.202216359","volume":"15","author":"O Hansson","year":"2022","unstructured":"Hansson, O. et al. The genetic regulation of protein expression in cerebrospinal fluid. EMBO Mol. Med. 15, e16359 (2022).","journal-title":"EMBO Mol. Med."},{"key":"1379_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"1379_CR34","doi-asserted-by":"publisher","first-page":"eabj1541","DOI":"10.1126\/science.abj1541","volume":"374","author":"M Pietzner","year":"2021","unstructured":"Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).","journal-title":"Science"},{"key":"1379_CR35","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712\u20131721 (2021).","journal-title":"Nat. Genet."},{"key":"1379_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","volume":"54","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat. Genet. 54, 593\u2013602 (2022).","journal-title":"Nat. Genet."},{"key":"1379_CR37","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat. Neurosci. 24, 1302\u20131312 (2021).","journal-title":"Nat. Neurosci."},{"key":"1379_CR38","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41588-024-01972-8","volume":"56","author":"D Western","year":"2024","unstructured":"Western, D. et al. Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer\u2019s disease. Nat. Genet. 56, 2672\u20132684 (2024).","journal-title":"Nat. Genet."},{"key":"1379_CR39","doi-asserted-by":"publisher","unstructured":"Mitchell, R. et al. UK Biobank Genetic Data: MRC-IEU Quality Control, version 2. University of Bristol https:\/\/doi.org\/10.5523\/BRIS.1OVAAU5SXUNP2CV8RCY88688V (2019).","DOI":"10.5523\/BRIS.1OVAAU5SXUNP2CV8RCY88688V"},{"key":"1379_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"1379_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/bioinformatics\/btaa726","volume":"37","author":"B Elsworth","year":"2021","unstructured":"Elsworth, B. & Gaunt, T. R. MELODI Presto: a fast and agile tool to explore semantic triples derived from biomedical literature. Bioinformatics 37, 583\u2013585 (2021).","journal-title":"Bioinformatics"},{"key":"1379_CR42","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 375, n2233 (2021).","journal-title":"BMJ"},{"key":"1379_CR43","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA 326, 1614\u20131621 (2021).","journal-title":"JAMA"},{"key":"1379_CR44","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191 (2010).","journal-title":"Bioinformatics"},{"key":"1379_CR45","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/nprot.2014.071","volume":"9","author":"TW Winkler","year":"2014","unstructured":"Winkler, T. W. et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192\u20131212 (2014).","journal-title":"Nat. Protoc."},{"key":"1379_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"BK Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291\u2013295 (2015).","journal-title":"Nat. Genet"},{"key":"1379_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng.2213","volume":"44","author":"J Yang","year":"2012","unstructured":"Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369\u2013375 (2012).","journal-title":"Nat. Genet."},{"key":"1379_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41588-023-01365-3","volume":"55","author":"S Dong","year":"2023","unstructured":"Dong, S. et al. Annotating and prioritizing human non-coding variants with RegulomeDB v.2. Nat. Genet. 55, 724\u2013726 (2023).","journal-title":"Nat. Genet."},{"key":"1379_CR49","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkv1340","volume":"44","author":"LD Ward","year":"2016","unstructured":"Ward, L. D. & Kellis, M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 44, D877\u2013D881 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1379_CR50","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gkr917","volume":"40","author":"LD Ward","year":"2012","unstructured":"Ward, L. D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930\u2013D934 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1379_CR51","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).","journal-title":"Nat. Commun."},{"key":"1379_CR52","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1379_CR53","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng, J. et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat. Genet. 52, 1122\u20131131 (2020).","journal-title":"Nat. Genet"},{"key":"1379_CR54","doi-asserted-by":"publisher","first-page":"eaba3066","DOI":"10.1126\/science.aba3066","volume":"369","author":"M Oliva","year":"2020","unstructured":"Oliva, M. et al. The impact of sex on gene expression across human tissues. Science 369, eaba3066 (2020).","journal-title":"Science"},{"key":"1379_CR55","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41588-018-0144-6","volume":"50","author":"P-R Loh","year":"2018","unstructured":"Loh, P.-R., Kichaev, G., Gazal, S., Schoech, A. P. & Price, A. L. Mixed-model association for biobank-scale datasets. Nat. Genet. 50, 906\u2013908 (2018).","journal-title":"Nat. Genet"},{"key":"1379_CR56","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue, S. et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 53, 1415\u20131424 (2021).","journal-title":"Nat. Genet."},{"key":"1379_CR57","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, e34408 (2018).","journal-title":"Elife"},{"key":"1379_CR58","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/bioinformatics\/btaa961","volume":"37","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. EpiGraphDB: a database and data mining platform for health data science. Bioinformatics 37, 1304\u20131311 (2021).","journal-title":"Bioinformatics"},{"key":"1379_CR59","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362, k601 (2018).","journal-title":"BMJ"},{"key":"1379_CR60","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10, e1004383 (2014).","journal-title":"PLoS Genet"},{"key":"1379_CR61","doi-asserted-by":"publisher","unstructured":"An efficient and robust tool for colocalisation: Pair-wise Conditional and Colocalisation (PWCoCo) | bioRxiv. https:\/\/doi.org\/10.1101\/2022.08.08.503158v1.","DOI":"10.1101\/2022.08.08.503158v1"},{"key":"1379_CR62","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u2013R98 (2014).","journal-title":"Hum. Mol. Genet"},{"key":"1379_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13104-024-06684-0","volume":"17","author":"B Woolf","year":"2024","unstructured":"Woolf, B. et al. MRSamePopTest: introducing a simple falsification test for the two-sample mendelian randomisation \u2018same population\u2019 assumption. BMC Res Notes 17, 27 (2024).","journal-title":"BMC Res Notes"},{"key":"1379_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/gepi.22551","volume":"48","author":"A Patel","year":"2024","unstructured":"Patel, A. et al. Robust use of phenotypic heterogeneity at drug target genes for mechanistic insights: Application of cis-multivariable Mendelian randomization to GLP1R gene region. Genet. Epidemiol. 48, 151\u2013163 (2024).","journal-title":"Genet. Epidemiol."},{"key":"1379_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41467-019-13870-3","volume":"11","author":"V Zuber","year":"2020","unstructured":"Zuber, V., Colijn, J. M., Klaver, C. & Burgess, S. Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization. Nat. Commun. 11, 29 (2020).","journal-title":"Nat. Commun."},{"key":"1379_CR66","doi-asserted-by":"publisher","unstructured":"Zheng, J. & Liu, J. Mendelian randomization study of GLP-1R effects on ovarian cancer subtypes mediated by metabolic factors. Zenodo https:\/\/doi.org\/10.5281\/zenodo.17994065 (2025).","DOI":"10.5281\/zenodo.17994065"},{"key":"1379_CR67","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12916-024-03272-8","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants. BMC Med. 22, 90 (2024).","journal-title":"BMC Med."},{"key":"1379_CR68","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.21037\/tlcr-22-34","volume":"11","author":"Y Feng","year":"2022","unstructured":"Feng, Y. et al. Causal effects of genetically determined metabolites on cancers included lung, breast, ovarian cancer, and glioma: a Mendelian randomization study. Transl. Lung Cancer Res. 11, 1302\u20131314 (2022).","journal-title":"Transl. Lung Cancer Res."},{"key":"1379_CR69","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3390\/cancers13205053","volume":"13","author":"D Freuer","year":"2021","unstructured":"Freuer, D. et al. Body fat distribution and risk of breast, endometrial, and ovarian cancer: a two-sample mendelian randomization study. Cancers 13, 5053 (2021).","journal-title":"Cancers"},{"key":"1379_CR70","doi-asserted-by":"publisher","first-page":"1234850","DOI":"10.1126\/science.1234850","volume":"342","author":"MA Nieto","year":"2013","unstructured":"Nieto, M. A. Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342, 1234850 (2013).","journal-title":"Science"},{"key":"1379_CR71","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.medj.2023.02.002","volume":"4","author":"Q-Q Xing","year":"2023","unstructured":"Xing, Q.-Q. et al. Global burden of common cancers attributable to metabolic risks from 1990 to 2019. Medicine 4, 168\u2013181 (2023).","journal-title":"Medicine"},{"key":"1379_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12935-025-03656-7","volume":"25","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. DLAT is involved in ovarian cancer progression by modulating lipid metabolism through the JAK2\/STAT5A\/SREBP1 signaling pathway. Cancer Cell Int. 25, 25 (2025).","journal-title":"Cancer Cell Int."},{"key":"1379_CR73","doi-asserted-by":"publisher","first-page":"m3773","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki, L. & Guntupalli, S. R. Treatment of epithelial ovarian cancer. BMJ 371, m3773 (2020).","journal-title":"BMJ"},{"key":"1379_CR74","doi-asserted-by":"publisher","first-page":"668151","DOI":"10.3389\/fonc.2021.668151","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. A review of the clinical characteristics and novel molecular subtypes of endometrioid ovarian cancer. Front. Oncol. 11, 668151 (2021).","journal-title":"Front. Oncol."},{"key":"1379_CR75","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/13697137.2021.1948994","volume":"24","author":"F Guidozzi","year":"2021","unstructured":"Guidozzi, F. Endometriosis-associated cancer. Climacteric 24, 587\u2013592 (2021).","journal-title":"Climacteric"},{"key":"1379_CR76","doi-asserted-by":"publisher","first-page":"21992","DOI":"10.1038\/s41598-023-49276-x","volume":"13","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Endometriosis and epithelial ovarian cancer: a two-sample Mendelian randomization analysis. Sci. Rep. 13, 21992 (2023).","journal-title":"Sci. Rep."},{"key":"1379_CR77","doi-asserted-by":"publisher","first-page":"10361","DOI":"10.3390\/ijms231810361","volume":"23","author":"AM Krasnyi","year":"2022","unstructured":"Krasnyi, A. M. et al. The levels of ghrelin, glucagon, visfatin and Glp-1 are decreased in the peritoneal fluid of women with endometriosis along with the increased expression of the CD10 protease by the macrophages. Int. J. Mol. Sci. 23, 10361 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1379_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng, Z. et al. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig Transduct. Target Ther. 9, 1\u201329 (2024).","journal-title":"Sig Transduct. Target Ther."},{"key":"1379_CR79","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.119.040331","volume":"139","author":"TAB Sanders","year":"2019","unstructured":"Sanders, T. A. B. Omega-6 fatty acids and cardiovascular disease. Circulation 139, 2437\u20132439 (2019).","journal-title":"Circulation"},{"key":"1379_CR80","doi-asserted-by":"crossref","unstructured":"Zhu, T., Lu, X.-T., Liu, Z.-Y. & Zhu, H.-L. Dietary linoleic acid and the ratio of unsaturated to saturated fatty acids are inversely associated with significant liver fibrosis risk: a nationwide survey. Front. Nutr. 9, 938645 (2022).","DOI":"10.3389\/fnut.2022.938645"},{"key":"1379_CR81","doi-asserted-by":"publisher","first-page":"10953","DOI":"10.1038\/s41598-018-29222-y","volume":"8","author":"S Jeyapal","year":"2018","unstructured":"Jeyapal, S. et al. Substitution of linoleic acid with \u03b1-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis. Sci. Rep. 8, 10953 (2018).","journal-title":"Sci. Rep."},{"key":"1379_CR82","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12937-016-0191-8","volume":"15","author":"E Ju\u00e1rez-Hern\u00e1ndez","year":"2016","unstructured":"Ju\u00e1rez-Hern\u00e1ndez, E., Ch\u00e1vez-Tapia, N. C., Uribe, M. & Barbero-Becerra, V. J. Role of bioactive fatty acids in nonalcoholic fatty liver disease. Nutr. J. 15, 72 (2016).","journal-title":"Nutr. J."},{"key":"1379_CR83","doi-asserted-by":"publisher","first-page":"eadm9805","DOI":"10.1126\/science.adm9805","volume":"387","author":"N Koundouros","year":"2025","unstructured":"Koundouros, N. et al. Direct sensing of dietary \u03c9-6 linoleic acid through FABP5-mTORC1 signaling. Science 387, eadm9805 (2025).","journal-title":"Science"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01379-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:05:01Z","timestamp":1770901501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01379-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01379-y","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. The funding sources had no role in the design of the study, collection and analysis of data, interpretation of results, and decision to publish.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}